Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;80(3):133-40.

A 22-year Northern Irish experience of carotid body tumours

Affiliations

A 22-year Northern Irish experience of carotid body tumours

Stephen O'Neill et al. Ulster Med J. 2011 Sep.

Abstract

Objectives: Carotid body tumours (CBTs) are rare vascular neoplasms originating in paraganglionic cells of the carotid bifurcation. The aim of this study was to review all patients diagnosed with CBTs in Northern Ireland.

Methods: A retrospective review was performed of all patients who had CBTs treated at our institutions between 1987 and 2009. Patient demographics, clinical symptomatology, investigative modality, therapeutic intervention, pathological analysis and long-term outcomes were assessed.

Results: Twenty-nine patients were identified with 33 CBTs and three glomus intravagale tumours (GITs). Six patients had bilateral CBTs (21%), one of whom had a synchronous GIT. Twenty-six patients underwent a total of 30 operative procedures for the resection of 28 CBTs and 3 GITs. Conventional operative treatment included subadventitial tumour excision. A vascular shunt facilitated arterial reconstruction following the removal of seven (23%) tumours and on six of these occasions (19%) continuity was restored with an interposition vein graft. For access the external carotid artery was ligated during the removal of four tumours (13%). Two tumours were considered malignant. No peri-operative mortalities were recorded. Immediate complications included peri-operative stroke secondary to an occluded vein graft (n=1), requirement of tracheostomy (n=2), emergency haematoma drainage (n=2) and transient cranial nerve damage (n=8). Late complications included pseudoaneurysm of vein graft with subsequent stoke (n=1), permanent cranial nerve damage (n=9), Horner's syndrome (n=1) and an asymptomatic vein graft occlusion (n=1). One patient had tumour recurrence two years post-operatively and died due to pulmonary metastases. Two other patients died of unrelated causes. All other patients remain well with no evidence of tumour recurrence at mean followup of 1801 days (range 159-9208 days).

Conclusion: Our long-term experience is comparable with other reported case series where surgical intervention conferred a long-term survival advantage despite associated cranial nerve co-morbidities.

Keywords: Carotid Body; Complications; Outcome; Surgery; Tumour.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Magnetic resonance angiogram (MRA) with intravenous gadolinium showing an avidly enhancing 4 x 3.5 x 2.5cm right CBT with multiple small blood vessels within (Note the characteristic splaying of the carotid bifurcation with the external carotid artery bowing over the tumour and the internal carotid artery slightly narrowed in calibre as it passes through)
Fig 2
Fig 2
Intra-operative exposure of a right-sided CBT which has splayed the carotid bifurcation
Fig 3
Fig 3
Undisturbed carotid arteries following excision of the right-sided CBT from figure 2 using the standard peri-adventitional dissection.
Fig 4
Fig 4
Gross specimen of the previously excised right-sided CBT (3 x 2.8 x 1.8cm, 6.5g)
Fig 5
Fig 5
Low power view of a typical CBT, showing a thinly encapsulated, well-circumscribed mass, with some adherent wisps of connective tissue (H&E x 1) (Top left). High-power magnification displays a nested growth pattern of monomorphic cells with granular eosinophilic cytoplasm (H&E x 400) (Top right). Immunopositivity within tumour cell cytoplasm for the neuroendocrine marker chromogranin A (immunoperoxidase x 400). (Bottom left). Immunopositivity within surrounding sustentacular cells for S100 (immunoperoxidase x 400) (Bottom right).

References

    1. Sajid MS, Hamilton G, Baker DM. A multicentre review of carotid body tumour management. Eur J Vasc Endovasc Surg. 2007;34(2):127–30. - PubMed
    1. Plukker JT, Brongers EP, Vermey A, Krikke A, van den Dungen JJ. Outcome of surgical treatment for carotid body paraganglioma. Br J Surg. 2001;88(10):1382–6. - PubMed
    1. Rodriguez-Cuevas S., Lopez-Garza J, Labastidia-Almendaro S. Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level. Head Neck. 1998;20(5):374–8. - PubMed
    1. Luna-Ortiz K, Rascon-Ortiz M, Villavicencio-Valencia V, Granados-Garcia M, Herrera-Gomez A. Carotid body tumours: a review of a 20 year experience. Oral Oncol. 2005;41(1):56–61. - PubMed
    1. Wang SJ, Wang MB, Barauskas TM, Calcaterra TC. Surgical management of carotid body tumors. Otolaryngol Head Neck Surg. 2000;123(3):202–6. - PubMed

LinkOut - more resources